Kevin Zhang

Kevin Zhang has been working in the venture capital industry since 2012. During their time at Upfront Ventures, they held the roles of Partner, Principal, Senior Associate, and Associate. Since 2017, they have been a Seed Lead and Board Member for several companies, including Canvas Medical, Tellie, Reveleer, Stray Bombay Company, Path, Switch Therapeutics, Pragma Platform, Omni Creator Products, and CertifyOS.

Kevin Zhang attended Harvard University from 2005 to 2009, where they earned an AB in Biology with a minor in Psychology.